|
|
.
See Category: Diseases of the eye and adnexa
See Header: Retinal telangiectasis
ICD-10 (CM) Code and Descriptor
|
H35.079 |
Retinal telangiectasis, unspecified eye
|
H35079 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 28.29%
|
21.46%
|
10.73%
|
11.22%
|
5.85%
|
5.37%
|
2.93%
|
4.88%
|
2.93%
|
1.46%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H35.079*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
25
|
25
|
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
20
|
20
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
10
|
10
|
|
92202
|
OPSCPY EXTND ON/MAC DRAW |
4
|
4
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
4
|
4
|
|
67028
|
INJECTION EYE DRUG |
3
|
3
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2
|
2
|
|
92083
|
EXTENDED VISUAL FIELD XM |
2
|
2
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1
|
1
|
|
80061
|
LIPID PANEL |
1
|
1
|
|
C9257
|
BEVACIZUMAB INJECTION |
1
|
5
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
1
|
1
|
|
80048
|
METABOLIC PANEL TOTAL CA |
1
|
1
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
1
|
1
|
|
G0467
|
FQHC VISIT, ESTAB PT |
1
|
1
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
1
|
1
|
|
92133
|
CPTRZD OPH DX IMG PST SGM ON |
1
|
1
|
|
92235
|
FLUORESCEIN ANGRPH MLTIFRAME |
1
|
1
|
|
J3590
|
UNCLASSIFIED BIOLOGICS |
1
|
5
|
|
J7999
|
COMPOUNDED DRUG, NOC |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H35.079 related to the following DRG Codes:
124-125
|
